- Home
- FRAF vs CNTX Comparison
FRAF vs CNTX Comparison
Compare FRAF & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- CNTX
- Stock Information
- Founded
- FRAF 1906
- CNTX 2015
- Country
- FRAF United States
- CNTX United States
- Employees
- FRAF N/A
- CNTX N/A
- Industry
- FRAF Major Banks
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- FRAF Finance
- CNTX Health Care
- Exchange
- FRAF Nasdaq
- CNTX Nasdaq
- Market Cap
- FRAF 127.4M
- CNTX 149.2M
- IPO Year
- FRAF N/A
- CNTX 2021
- Fundamental
- Price
- FRAF $32.20
- CNTX $2.32
- Analyst Decision
- FRAF
- CNTX Strong Buy
- Analyst Count
- FRAF 0
- CNTX 3
- Target Price
- FRAF N/A
- CNTX $6.50
- AVG Volume (30 Days)
- FRAF 3.1K
- CNTX 78.6K
- Earning Date
- FRAF 10-22-2024
- CNTX 08-07-2024
- Dividend Yield
- FRAF 3.98%
- CNTX N/A
- EPS Growth
- FRAF N/A
- CNTX N/A
- EPS
- FRAF 3.11
- CNTX N/A
- Revenue
- FRAF $69,344,000.00
- CNTX N/A
- Revenue This Year
- FRAF N/A
- CNTX N/A
- Revenue Next Year
- FRAF N/A
- CNTX N/A
- P/E Ratio
- FRAF $10.36
- CNTX N/A
- Revenue Growth
- FRAF 3.47
- CNTX N/A
- 52 Week Low
- FRAF $25.11
- CNTX $0.77
- 52 Week High
- FRAF $35.00
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- FRAF 71.24
- CNTX 44.78
- Support Level
- FRAF $31.51
- CNTX $2.41
- Resistance Level
- FRAF $32.73
- CNTX $2.55
- Average True Range (ATR)
- FRAF 0.36
- CNTX 0.12
- MACD
- FRAF 0.19
- CNTX -0.04
- Stochastic Oscillator
- FRAF 83.89
- CNTX 26.35
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.